首页> 美国卫生研究院文献>Scientific Reports >Osteogenesis of peripheral blood mesenchymal stem cells in self assembling peptide nanofiber for healing critical size calvarial bony defect
【2h】

Osteogenesis of peripheral blood mesenchymal stem cells in self assembling peptide nanofiber for healing critical size calvarial bony defect

机译:自组装肽纳米纤维修复外周血间充质干细胞成骨关键尺寸颅骨缺损

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peripheral blood mesenchymal stem cells (PBMSCs) may be easily harvested from patients, permitting autologous grafts for bone tissue engineering in the future. However, the PBMSC’s capabilities of survival, osteogenesis and production of new bone matrix in the defect area are still unclear. Herein, PBMSCs were seeded into a nanofiber scaffold of self-assembling peptide (SAP) and cultured in osteogenic medium. The results indicated SAP can serve as a promising scaffold for PBMSCs survival and osteogenic differentiation in 3D conditions. Furthermore, the SAP seeded with the induced PBMSCs was splinted by two membranes of poly(lactic)-glycolic acid (PLGA) to fabricate a composited scaffold which was then used to repair a critical-size calvarial bone defect model in rat. Twelve weeks later the defect healing and mineralization were assessed by H&E staining and microcomputerized tomography (micro-CT). The osteogenesis and new bone formation of grafted cells in the scaffold were evaluated by immunohistochemistry. To our knowledge this is the first report with solid evidence demonstrating PBMSCs can survive in the bone defect area and directly contribute to new bone formation. Moreover, the present data also indicated the tissue engineering with PBMSCs/SAP/PLGA scaffold can serve as a novel prospective strategy for healing large size cranial defects.
机译:外周血间充质干细胞(PBMSC)可以很容易地从患者身上收集,从而允许将来进行骨组织工程的自体移植。然而,PBMSC在缺损区域的存活,成骨和新骨基质的生产能力仍不清楚。在此,将PBMSCs接种到自组装肽(SAP)的纳米纤维支架中,并在成骨培养基中培养。结果表明,SAP可以作为PBMSC在3D条件下存活和成骨分化的有前途的支架。此外,用两片聚(乳酸)-乙醇酸(PLGA)膜将接种有诱导的PBMSC的SAP夹板,以制造复合支架,然后将其用于修复大鼠的关键尺寸颅盖骨缺损模型。十二周后,通过H&E染色和微型计算机断层扫描(micro-CT)评估缺损的愈合和矿化。通过免疫组织化学评估支架中移植细胞的成骨性和新骨形成。据我们所知,这是第一份有确凿证据的报告,证明PBMSC可以在骨缺损区域生存,并直接促进新的骨形成。此外,目前的数据还表明,用PBMSCs / SAP / PLGA支架进行的组织工程可以作为治愈大尺寸颅骨缺损的一种新的前瞻性策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号